181 related articles for article (PubMed ID: 22646534)
1. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
[TBL] [Abstract][Full Text] [Related]
2. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
3. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
6. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane.
Hieda M; Isokane M; Koizumi M; Higashi C; Tachibana T; Shudou M; Taguchi T; Hieda Y; Higashiyama S
J Cell Biol; 2008 Feb; 180(4):763-9. PubMed ID: 18299347
[TBL] [Abstract][Full Text] [Related]
7. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
8. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer.
Murayama Y; Miyagawa J; Shinomura Y; Kanayama S; Isozaki K; Yamamori K; Mizuno H; Ishiguro S; Kiyohara T; Miyazaki Y; Taniguchi N; Higashiyama S; Matsuzawa Y
Int J Cancer; 2002 Apr; 98(4):505-13. PubMed ID: 11920609
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.
Nanba D; Mammoto A; Hashimoto K; Higashiyama S
J Cell Biol; 2003 Nov; 163(3):489-502. PubMed ID: 14597771
[TBL] [Abstract][Full Text] [Related]
10. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
Miyazono K
J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
[TBL] [Abstract][Full Text] [Related]
11. The carboxyl-terminal fragment of pro-HB-EGF reverses Bcl6-mediated gene repression.
Kinugasa Y; Hieda M; Hori M; Higashiyama S
J Biol Chem; 2007 May; 282(20):14797-806. PubMed ID: 17392284
[TBL] [Abstract][Full Text] [Related]
12. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
13. Nuclear translocation of pro-amphiregulin induces chemoresistance in gastric cancer.
Yoshida M; Shimura T; Fukuda S; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Nakazawa T; Higashiyama S; Joh T
Cancer Sci; 2012 Apr; 103(4):708-15. PubMed ID: 22320154
[TBL] [Abstract][Full Text] [Related]
14. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.
Uetani T; Nakayama H; Okayama H; Okura T; Higaki J; Inoue H; Higashiyama S
J Biol Chem; 2009 May; 284(18):12399-409. PubMed ID: 19193634
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor.
Wang X; Mizushima H; Adachi S; Ohishi M; Iwamoto R; Mekada E
Cell Struct Funct; 2006; 31(1):15-27. PubMed ID: 16557002
[TBL] [Abstract][Full Text] [Related]
16. A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma.
Adam RM; Danciu T; McLellan DL; Borer JG; Lin J; Zurakowski D; Weinstein MH; Rajjayabun PH; Mellon JK; Freeman MR
Cancer Res; 2003 Jan; 63(2):484-90. PubMed ID: 12543806
[TBL] [Abstract][Full Text] [Related]
17. Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress.
Kim J; Adam RM; Freeman MR
Cancer Res; 2005 Sep; 65(18):8242-9. PubMed ID: 16166300
[TBL] [Abstract][Full Text] [Related]
18. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
[TBL] [Abstract][Full Text] [Related]
19. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor.
Nanba D; Higashiyama S
Cytokine Growth Factor Rev; 2004 Feb; 15(1):13-9. PubMed ID: 14746810
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma.
Naef M; Yokoyama M; Friess H; Büchler MW; Korc M
Int J Cancer; 1996 May; 66(3):315-21. PubMed ID: 8621250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
